Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    11013380 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Enrolling by invitation Proof-of-Concept Trial of Palonosetron and Olanzapine Without Dexamethasone for the Prevention of CIN
Condition: Chemotherapy-induced Nausea and Vomiting
Interventions: Drug: Olanzapine;   Drug: Palonosetron
2 Unknown  Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes
Conditions: Cancer;   Solid Tumor;   Hematologic Malignancy
Intervention:

Study has passed its completion date and status has not been verified in more than two years.